Key result
EHR-integrated screening is linked to a ~15% annual increase in low-risk CVD detection.
Why the study?
Although Iran's IraPEN program embeds WHO-based cardiovascular risk scoring into the national EHR system, how risk-category distributions and screening coverage have shifted over time remained poorly understood.
Cross-Sectional (n=167,250)
Yes
Integration of WHO cardiovascular risk scoring into a primary care EHR system in southern Iran led to substantial expansion of screening coverage (particularly in adults ≥60 years) and increased detection of individuals with low-to-moderate predicted 10-year CVD risk between 2019 and 2025.
Answers are grounded in this paper and cite their sources.
EHR-integrated screening expansion was associated with greater low-to-moderate CVD risk detection; leaves open effects on outcomes and resource allocation.
Background Cardiovascular disease remains the leading cause of premature death in Iran and across low- and middle-income countries. Iran's IraPEN program embeds WHO-based cardiovascular risk scoring into the national electronic health record (EHR) system, yet how risk-category distributions and screening coverage have shifted over time remains poorly understood. Methods This repeated cross-sectional study was conducted using 167,250 cardiovascular risk assessments among adults aged 40–80 years in Jahrom County, southern Iran, between 2019 and 2025. Ten-year CVD risk was estimated using the WHO Eastern Mediterranean risk prediction model. Age-standardized proportions (ASPs) per 1,000 screened individuals were calculated using the WHO standard population, and temporal trends were assessed by log-linear regression, reported as annual percent change (APC) with 95% confidence intervals. Results Women accounted for 54.7% of assessments. The majority of participants fell into the ≤ 10% risk category (86.8%), with 3.5% classified as moderate risk (10–20%). ASPs rose significantly in both the ≤ 10% (APC = 15.1%; p = 0.009) and 10–20% (APC = 14%; p = 0.02) categories. Higher-risk categories trended upward but without statistical significance. Among women, the > 30% risk category showed a statistically significant increase. Screening coverage expanded substantially, most notably among adults aged ≥ 60 years. Conclusion Growth in EHR-integrated cardiovascular screening coincided with greater detection of individuals across all risk strata. These trends most likely reflect a combination of expanded coverage, improved case ascertainment, and changing cardiometabolic profiles within the screened population.
No takes yet. Share an insight, caveat, or question.
Hosseini et al. (2026) conducted a cross-sectional in Cardiovascular disease risk (n=167,250). IraPEN EHR-integrated cardiovascular risk assessment program vs. Baseline year (2019) was evaluated on Age-standardized proportion per 1,000 screened individuals in the ≤10% 10-year predicted cardiovascular risk category (APC 15.06%, 95% CI 7.71-22.92, p=0.009). EHR-integrated cardiovascular screening increased detection of ≤10% and 10–20% 10-year CVD risk strata from 2019 to 2025.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: